P04.14ICD-10-CM 2027 · Billable
Newborn affected by maternal use of opiates
Sibling codes
P04.11– Newborn affected by maternal antineoplastic chemotherapyP04.12– Newborn affected by maternal cytotoxic drugsP04.13– Newborn affected by maternal use of anticonvulsantsP04.15– Newborn affected by maternal use of antidepressantsP04.16– Newborn affected by maternal use of amphetaminesP04.17– Newborn affected by maternal use of sedative-hypnoticsP04.1A– Newborn affected by maternal use of anxiolyticsP04.18– Newborn affected by other maternal medicationP04.19– Newborn affected by maternal use of unspecified medication
Inherited from P04.1: Newborn affected by other maternal medication
Code first
Excludes1
Excludes2
Inherited from P04: Newborn affected by noxious substances transmitted via placenta or breast milk
Code first
- any current condition in newborn, if applicable
Excludes2
- congenital malformations (
Q00-Q99) - encounter for observation of newborn for suspected diseases and conditions ruled out (
Z05.-) - neonatal jaundice from excessive hemolysis due to drugs or toxins transmitted from mother (
P58.4) - newborn in contact with and (suspected) exposures hazardous to health not transmitted via placenta or breast milk (
Z77.-)
Includes
- nonteratogenic effects of substances transmitted via placenta
Part of: P04.1: Newborn affected by other maternal medication › P04: Newborn affected by noxious substances transmitted via placenta or breast milk